]>
IRCT20190121042444N3 IRCT 2020-07-04 Shahid Beheshti University of Medical Sciences Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients 2020-02-20 anticipated 78 Complete https://irct.ir/trial/49132 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this method, based on the table of random numbers, first the number of samples is entered using a computer and each two-digit code is assigned. The researcher randomly selects a point in the Weston line. This table selects a point if the desired number is smaller than the sample size. Work continues until the sample size is complete, Blinding description: In this study, desferal supplement medication is taken by nurse . Here, nurse knows the type of complementary medicine. So the researcher is blind here. 3 COVID-19. Intervention 1: In this study, randomly placed in a group of patients with desferal supplementation at a dose of 20 to 60 mg by weight over 8 to 12 hours, along with 100 mg of vitamin C ampoules at the time of hospitalization in the corona section, followed by ferritin and CRP by The patient's blood test is checked to compare their differences with before the intervention. Intervention 2: In the control group, desferal supplementation is not given at a dose of 20 to 60 mg per kg body weight with 100 mg of vitamin C ampoules, and ferritin and CRP tests are sent to the patient. They are also compared. Yes - There is a plan to make this available What will be shared: Only part of the data, such as information about the main consequence or the like, can be shared. When: Start of access period from 1400 To whom: Only for researchers in academic and scientific institutions Conditions: Only data analysis is possible Where to obtain: Dr. Faranak Behnaz, Address: Tehran, Tajrish Square, Shohada Experience Hospital, Tel: 0098212271174 How to obtain: After submitting the application, a maximum of one week will be answered Comments:
public Faranak Behnaz
Shohada Hospital, Tajrish SQ, Tehran , Iran
Tehran Iran (Islamic Republic of) 1985711151 +98 21 2274 1174 faranak.behnaz@gmail.com Shahid Beheshti University of Medical Sciences scientific Seyed Ebrahim Sadeghzadeh Sadat
Shohada Hospital,Tajrish SQ
Tehran Iran (Islamic Republic of) 1985711151 +98 21 2274 1174 sadat13584@gmail.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Get infected with a viral infection COVID-19 High serum ferritin levels Increased inflammatory factor in the blood no limit no limit Both Patients with renal insufficiency Consumption of desferal supplementary in them is contraindicated U07.1 U07.1 COVID posetive Treatment - Drugs N/A In this study, randomly placed in a group of patients with desferal supplementation at a dose of 20 to 60 mg by weight over 8 to 12 hours, along with 100 mg of vitamin C ampoules at the time of hospitalization in the corona section, followed by ferritin and CRP by The patient's blood test is checked to compare their differences with before the intervention In the control group, desferal supplementation is not given at a dose of 20 to 60 mg per kg body weight with 100 mg of vitamin C ampoules, and ferritin and CRP tests are sent to the patient. They are also compared CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement. CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement. Shahid Beheshti University of Medical Sciences Approved 2020-06-23 Ethics committee of Shahid Behesti University of Medical Sciences Yaman Ave,Velenjak Tehran Tehran Iran (Islamic Republic of)